---
title: "Jefferies Sticks to Its Buy Rating for Covista (CVSA)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296118987.md"
description: "Jefferies analyst Jack Slevin reiterated a Buy rating on Covista (CVSA) with a $175 price target. Slevin, a 4-star analyst in the Healthcare sector, maintains this stance. The broader market consensus for Covista is also a Strong Buy, with an average price target of $166."
datetime: "2026-08-17T14:05:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296118987.md)
  - [en](https://longbridge.com/en/news/296118987.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296118987.md)
generator: "portal-rs"
---

# Jefferies Sticks to Its Buy Rating for Covista (CVSA)

Jefferies analyst Jack Slevin reiterated a Buy rating on Covista today and set a price target of $175.00.

### Summer Sale - Claim 70% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

According to TipRanks, Slevin is a 4-star analyst with an average return of 22.0% and a 60.71% success rate. Slevin covers the Healthcare sector, focusing on stocks such as AdaptHealth, Astrana Health, and Lifestance Health Group.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Covista with a $166.00 average price target.

### Related Stocks

- [CVSA.US](https://longbridge.com/en/quote/CVSA.US.md)
- [JEF.US](https://longbridge.com/en/quote/JEF.US.md)
- [AHCO.US](https://longbridge.com/en/quote/AHCO.US.md)
- [ASTH.US](https://longbridge.com/en/quote/ASTH.US.md)
- [LFST.US](https://longbridge.com/en/quote/LFST.US.md)

## Related News & Research

- [Covista Inc. Confronts Rising AI-Driven Compliance, Cost, and Reputation Risks](https://longbridge.com/en/news/295388736.md)
- [Covista (CVSA) Gets a Buy from Barrington](https://longbridge.com/en/news/285746015.md)
- [Jefferies Sticks to Their Buy Rating for Abbott Laboratories (ABT)](https://longbridge.com/en/news/296645903.md)
- [Wedbush Keeps Their Buy Rating on IDEAYA Biosciences (IDYA)](https://longbridge.com/en/news/296510282.md)
- [Jefferies Reaffirms Their Buy Rating on Compagnie Générale des Établissements Michelin (MGDDF)](https://longbridge.com/en/news/296390494.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**